Immunovant Inc (IMVT)

Mar 11, 2026

Immunovant Stock Up 30% as Investor Trims Stake by $3 Million, But Here's Why It Still Seems Bullish - Yahoo Finance

Mar 11, 2026

Mar 08, 2026

Immunovant, Inc. (IMVT) analysts raise price targets following Q3 earnings update - MSN

Mar 08, 2026

Mar 08, 2026

The Technical Signals Behind (IMVT) That Institutions Follow - Stock Traders Daily

Mar 08, 2026

Mar 05, 2026

Immunovant Stock Surges 17% in 3 Months: What's Driving It? - Yahoo Finance

Mar 05, 2026

Mar 05, 2026

Immunovant Stock Pre-Market (+8.1%) : Key Analyst Upgrade Cites Pipeline Confidence - Trefis

Mar 05, 2026

Mar 05, 2026

Vanguard Group Inc. Has $110.05 Million Holdings in Immunovant, Inc. $IMVT - MarketBeat

Mar 05, 2026

Mar 05, 2026

TD Asset Management Inc Sells 56,752 Shares of Immunovant, Inc. $IMVT - MarketBeat

Mar 05, 2026

Mar 05, 2026

Citigroup Inc. Sells 75,860 Shares of Immunovant, Inc. $IMVT - MarketBeat

Mar 05, 2026

Mar 04, 2026

Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update - Bitget

Mar 04, 2026

Mar 04, 2026

How Investors Are Reacting To Immunovant (IMVT) Narrower Q3 Loss and 2026 Autoimmune Trial Milestones - simplywall.st

Mar 04, 2026

Mar 03, 2026

Immunovant, Inc. (IMVT) Stock Analysis: A Compelling 48.2% Upside Potential in the Biotech Sector - DirectorsTalk Interviews

Mar 03, 2026

Feb 27, 2026

Immunovant (IMVT) COO executes 3,238-share sell-to-cover tax transaction - Stock Titan

Feb 27, 2026

Feb 25, 2026

Immunovant stock hits 52-week high at 28.32 USD By Investing.com - Investing.com Australia

Feb 25, 2026

Feb 25, 2026

Immunovant (NASDAQ:IMVT) Sets New 52-Week HighHere's What Happened - MarketBeat

Feb 25, 2026

Feb 25, 2026

Immunovant stock hits 52-week high at 28.32 USD - Investing.com

Feb 25, 2026

Feb 25, 2026

Precision Trading with Immunovant Inc. (IMVT) Risk Zones - Stock Traders Daily

Feb 25, 2026

Feb 25, 2026

Immunovant, Inc. (IMVT) Stock Analysis: Unpacking A 51% Potential Upside - DirectorsTalk Interviews

Feb 25, 2026

Feb 24, 2026

IMVT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 23, 2026

Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com

Feb 23, 2026

Feb 22, 2026

Assessing Immunovant (IMVT) Valuation As Shares Deliver A 25% One Year Return - Yahoo Finance

Feb 22, 2026

Feb 20, 2026

What are Immunovant Inc.’s earnings expectationsOil Prices & Risk Managed Investment Strategies - mfd.ru

Feb 20, 2026

Feb 19, 2026

Aberdeen Group plc Has $15.83 Million Stock Position in Immunovant, Inc. $IMVT - MarketBeat

Feb 19, 2026

Feb 17, 2026

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT) - PR Newswire

Feb 17, 2026

Feb 17, 2026

Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Feb 17, 2026

Feb 16, 2026

Will Immunovant Inc. stock recover faster than marketTrade Analysis Report & Stepwise Swing Trade Plans - mfd.ru

Feb 16, 2026

Feb 14, 2026

What are analysts’ price targets for Immunovant Inc.Quarterly Trade Report & Capital Efficient Trading Techniques - mfd.ru

Feb 14, 2026

Feb 14, 2026

Technical Reactions to IMVT Trends in Macro Strategies - Stock Traders Daily

Feb 14, 2026

Feb 13, 2026

Why hedge funds are buying Immunovant Inc. stockMarket Trend Summary & Real-Time Volume Spike Alerts - mfd.ru

Feb 13, 2026

Feb 13, 2026

FY2026 EPS Forecast for Immunovant Increased by Analyst - MarketBeat

Feb 13, 2026

Feb 12, 2026

FY2030 EPS Estimates for Immunovant Raised by HC Wainwright - MarketBeat

Feb 12, 2026

Feb 12, 2026

Is now the right time to enter Immunovant Inc.Weekly Gains Report & Trade Opportunity Analysis Reports - mfd.ru

Feb 12, 2026

Feb 11, 2026

Immunovant shares climb 7% as fiscal Q3 loss comes in better than expected - MSN

Feb 11, 2026

Feb 11, 2026

Immunovant (IMVT) Gets a Buy from Oppenheimer - The Globe and Mail

Feb 11, 2026

Feb 10, 2026

Immunovant (NASDAQ:IMVT) Given Buy Rating at HC Wainwright - MarketBeat

Feb 10, 2026

Feb 10, 2026

Immunovant stock hits all-time high at 27.87 USD By Investing.com - Investing.com Australia

Feb 10, 2026

Feb 09, 2026

Immunovant Rides Brepocitinib Momentum Into 2026 - TipRanks

Feb 09, 2026

Feb 09, 2026

IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus - Finviz

Feb 09, 2026

Feb 09, 2026

Immunovant stock hits all-time high at 27.87 USD - Investing.com

Feb 09, 2026

Feb 09, 2026

Immunovant (NASDAQ:IMVT) Hits New 12-Month High After Earnings Beat - MarketBeat

Feb 09, 2026

Feb 08, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Immunovant (IMVT) and Roivant Sciences (ROIV) - The Globe and Mail

Feb 08, 2026

Feb 07, 2026

All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy - MSN

Feb 07, 2026

Feb 07, 2026

A Look At Immunovant (IMVT) Valuation After Trial Progress Updates And Extended Cash Runway - Yahoo Finance

Feb 07, 2026

Feb 07, 2026

Immunovant, Inc. (NASDAQ:IMVT) Q3 2026 Earnings Call Transcript - Insider Monkey

Feb 07, 2026

Feb 07, 2026

Immunovant Inc (IMVT) Shares Surge 12.4% on Q3 Earnings Beat, Pipeline Milestones - AlphaStreet News

Feb 07, 2026

Feb 07, 2026

Decoding Immunovant Inc (IMVT): A Strategic SWOT Insight - GuruFocus

Feb 07, 2026

Feb 06, 2026

Does Immunovant’s (IMVT) Narrower Quarterly Per‑Share Loss Reframe Its Long‑Term Risk‑Reward Equation? - simplywall.st

Feb 06, 2026

Feb 06, 2026

Earnings call transcript: Immunovant beats Q3 2026 EPS expectations, stock surges - Investing.com Nigeria

Feb 06, 2026

Feb 06, 2026

Immunovant (NASDAQ:IMVT) Posts Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat

Feb 06, 2026

Feb 06, 2026

Earnings call transcript: Immunovant beats Q3 2026 EPS expectations, stock surges By Investing.com - Investing.com South Africa

Feb 06, 2026

Feb 06, 2026

Immunovant (IMVT) Q2 2025 Earnings Call Transcript - AOL.com

Feb 06, 2026